bipolar%20disorder
BIPOLAR DISORDER
Bipolar I disorder is primarily defined by manic or mixed episodes that last for at least 7 days, or very severe manic symptoms needing immediate hospital care. The patient also has depressive episodes which may last for at least 2 weeks.
Bipolar II disorder is usually misdiagnosed. It is characterized by occurence of ≥1 major depressive episodes with at least 1 hypomanic episode.
Cyclothymic disorder or cyclothymia is a mild form of bipolar disorder. Patients have  episodes of hypomania alternating with mild depression that lasts for 2 years.
Rapid-cycling bipolar disorder patients have ≥4 episodes of major depression, mania, hypomania or mixed symptoms within a year.
Drug Information

Indication: Maintenance treatment of schizophrenia in adult patients.

Indication: Schizophrenia. Acute treatment of manic or mixed episodes associated w/ bipolar I disorder.

Indication: Patients w/ schizophrenia who are non-responsive to or intolerant of classic antipsychotics. Recurrent suicida...

Indication: Schizophrenia.

Indication: Acute & maintenance treatment of schizophrenia in adults.

Indication: Risperdal Schizophrenia including 1st episode psychoses, acute schizophrenic exacerbations, chronic schizophre...

Indication: Acute & maintenance treatment of schizoprenia. Acute manic episodes associated w/ bipolar I disorder.

Indication: Schizophrenia & acute manic episodes w/ bipolar I disorder.

Indication: Adjunctive or monotherapy in treatment of epilepsy for partial & generalized seizures, including tonic-clo...

Indication: Acute & maintenance treatment of schizophrenia. Alleviates secondary affective symptoms associated w/ schi...

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.